V. Masilamani

Discriminating Benign and Malignant Brain Tumors By Spectral Analysis of Cerebrospinal Fluid

V. Masilamani, R. Vidhya Shree, Ajay T. Prasad, Kannan Ramamurthy, Chellappan Selvaraju, Wafa Mohammed Alsaleh, Tahani A. Alrebdi, Trinka Vijmasi, A. Thiruvalluvan & V. Chandramouleeswaran · Journal of Pharmaceutical Research International · 2022

The preliminary study is concerned with an innovative technique for the discrimination of malignant brain tumor from benign with reasonable sensitivity and specificity. The entire study is based on the relative fluorescence intensity and life-time of bio-fluorophores like tryptop...

Open access Research Article 10.9734/jpri/2022/v34i49A36425

Ultra Violet and Visible Light as Therapeutic Tools for COVID-19

V. Masilamani, R. Vidhya Shree, Wafa M Al-Saleh & Lilia Coronato Courrol · Journal of Pharmaceutical Research International · 2021

Covid-19 is a disease which has become pandemic because of transmission of the tiny, single stranded virus, called SARS-CoV-2 or SARS-2.  It has infected so far 168 million people with a death toll of 3.6 million in 210 countries. The world has seen worse pandemics but this COVID...

Open access Research Article 10.9734/jpri/2021/v33i60B35019